Clinical oral investigations · 2025
A comparative assessment of orthodontically induced root resorption and alveolar bone changes in adolescent orthodontic patients undergoing Micro-Osteoperforations assisted canine retraction: A Split-Mouth randomized controlled trial.
СтатьяРандомизированное исследованиеСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yadav Deepanshi, Batra Puneet, Talwar Aditya, Sonar Saurabh, Srivastava Amit
Аннотация
INTRODUCTION: Micro-osteoperforation (MOP) is a minimally invasive technique aimed at accelerating orthodontic tooth movement (OTM) by stimulating localised bone remodelling. However, its impact on root resorption, alveolar bone levels, and inflammatory mediators such as interleukin-4 (IL-4) requires further investigation. This study assessed root resorption, alveolar bone changes, canine angulation, rate of retraction, and IL-4 expression associated with MOP-assisted canine retraction.
METHODS: A randomised split-mouth controlled clinical trial was conducted on 20 patients (mean age: 19.70 ± 2.38 years). Patients were randomised according to the SNOSE criteria, with one side receiving MOPs distal to the canine; the contralateral side served as control for both maxillary and mandibular dentition. Retraction was performed using 9 mm NiTi closed coil springs with 150 g force for 7.6 ± 1.2 months. Pre- and post-retraction CBCT scans evaluated linear root resorption and alveolar bone changes. Digital models assessed canine movement and angulation. Gingival crevicular fluid was collected at four intervals and analyzed for IL-4 using ELISA.
RESULTS: Maxillary and mandibular canines showed relatively greater root resorption (1.03 mm and 0.57 mm, respectively) and crestal bone loss (0.893 mm and 0.56 mm, respectively) on the MOP side (p < 0.05). The rate of canine retraction was higher with MOP (maxilla: 1.28 ± 0.17 mm/month; mandible: 1.36 ± 0.16 mm/month) compared to control (p < 0.001) with increased canine tipping noted on MOP side. IL-4 levels showed a transient decline post-MOP, recovering by day 28.
CONCLUSIONS: MOP effectively accelerates OTM but increases the risk of root and alveolar bone resorption. The associated reduction in IL-4 may contribute to enhanced osteoclastic activity. Clinical application should be case-dependent, with caution in patients at risk of periodontal or root compromise.
METHODS: A randomised split-mouth controlled clinical trial was conducted on 20 patients (mean age: 19.70 ± 2.38 years). Patients were randomised according to the SNOSE criteria, with one side receiving MOPs distal to the canine; the contralateral side served as control for both maxillary and mandibular dentition. Retraction was performed using 9 mm NiTi closed coil springs with 150 g force for 7.6 ± 1.2 months. Pre- and post-retraction CBCT scans evaluated linear root resorption and alveolar bone changes. Digital models assessed canine movement and angulation. Gingival crevicular fluid was collected at four intervals and analyzed for IL-4 using ELISA.
RESULTS: Maxillary and mandibular canines showed relatively greater root resorption (1.03 mm and 0.57 mm, respectively) and crestal bone loss (0.893 mm and 0.56 mm, respectively) on the MOP side (p < 0.05). The rate of canine retraction was higher with MOP (maxilla: 1.28 ± 0.17 mm/month; mandible: 1.36 ± 0.16 mm/month) compared to control (p < 0.001) with increased canine tipping noted on MOP side. IL-4 levels showed a transient decline post-MOP, recovering by day 28.
CONCLUSIONS: MOP effectively accelerates OTM but increases the risk of root and alveolar bone resorption. The associated reduction in IL-4 may contribute to enhanced osteoclastic activity. Clinical application should be case-dependent, with caution in patients at risk of periodontal or root compromise.